1. Purdue joining pharma’s top settlement list alongside Merck, GSK, and Pfizer — Biosimilars running into more roadblocks in the US — Big Pharma companies pay for exclusive access to UK genetic data — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Eisai is officially the place to leave

Discussion in 'Eisai' started by anonymous, Apr 1, 2017 at 8:34 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Eisai once was a respectable company that sales professionals once enjoyed working for. In its heyday reps proudly sold Aciphex and Aricept. These days reps struggle to sell products with box warnings such as homicidal ideation and the company just keeps raising the goal while downsizing. Eisai laid-off and take away the best epilepsy reps in the company from the institutions/hospitals that are writing a majority of product. In return for your years of service and hard work you are now assigned a territory that includes multiple states and a NICM rep that will take over your business. In the pasts you may have had 60 scripts a week you will now have a territory that doesn't even bring in 30 scripts a quarter. Remember these NSS roles are to bring in 75% of the company business. Most sane reps are jobviously hunting and punching their ticket out of this prison camp there are a few naive reps that are hanging on for dear life tryingoes to make it to 2022 for a dementia med. Eisai is using you and will rid it's self of you. If they can get rid of exceeds sales epilepsy experienced reps to replace them with new pexpletive without any experience what makes you think theyou will keep you just because you sold Aricept? Wake up minions get out while you can negotiate pay else where.
     
  2. anonymous

    anonymous Guest

    sort of well said
     
  3. anonymous

    anonymous Guest

    I can't wait to attend the POA. There'll be more smoke blown than a Cheech and Chong movie. They'll tell us once again how the Challenger sales model will put us over the top. But don't roll your eyes Ivan will be watching you. Also can't wait to see how the NICM reps "challenge" the doors that will be slammed in their faces each day.
     
  4. anonymous

    anonymous Guest

    Sorry about original post mistakes. Couldn't see text so words were typing over others. Feeling bad for anyone that has to attend POA. Can you imagine the strangeness of division yet pretendness of let's all work together?
     
  5. anonymous

    anonymous Guest

    People jumping ship in record numbers in the home office as well....
     
  6. anonymous

    anonymous Guest

    Like who?
     
  7. anonymous

    anonymous Guest

    Everyone with a brain and a shred of self respect left .
     
  8. anonymous

    anonymous Guest

    AS did the dude.
     
  9. anonymous

    anonymous Guest

    Some make a choice to stay. They're the few reps who have been with the company forever and have managed to avoid layoffs. Not many of them, but they stay because it's the only thing they know, and a big severance package awaits should they be cut.
     
  10. anonymous

    anonymous Guest

    Otherwise called dead weight
     
  11. anonymous

    anonymous Guest

    Eisai is the short scholl bus of the pharma industry.
     
  12. anonymous

    anonymous Guest

    hiring Hawthorne was a bad idea. He has no strategic mindset. He is used to being told what to do, checking boxes and kissing up. Not the guy who is going to help us succeed.
     
  13. anonymous

    anonymous Guest

    mark my words he'll be gone by this time next year.
     
  14. anonymous

    anonymous Guest


    In my brief time at Eisai it is apparent yes men with little substance who check boxes and don't think is exactly what they want and they deliberately hire and promote it.
     
  15. anonymous

    anonymous Guest

    So.......who's the west coast Oncology RD? How is he/she to work for? Do they they know Oncology or just does asinine things?
     
  16. anonymous

    anonymous Guest

    Hawthorne should be right at home then. Probably already trying to leverage his brief stint as CCO into a CEO role somewhere anyway. Self serving jack hole.
     
  17. anonymous

    anonymous Guest

    I bet everyone is super excited for poa! There is going to be lots of fist pumping music and lots of standing ovations for the people who just downsized half the epilepsy sales force. Does it make sense to lay off good (few) good reps then rehire someone inexperienced in that territory? One bad year in NG ranking should not defined a person. I can't wait to see all of the kool-aid drinkers at the meeting. Let's go check the box it's what PH does best just before he is fired. Sanofi is glad to be rid of him.
     
  18. anonymous

    anonymous Guest

    And can someone please also tell me who the Oncology RD is on the east coast? How is he/she to work for?
     
  19. anonymous

    anonymous Guest

    Tory B. Ask around.
     
  20. anonymous

    anonymous Guest

    Eisai is the land of mediocrity- so it's hard to imagine anyone is hard or challenging to work for- especially if you are a white, middle-aged, male, second rate pharma has-been. Hitch your wagon to that rising star and oh the places you will go!